Inside Exact Sciences’ $2.8B Genomic Health buy: A false start, rejections and a mysterious last-minute party


A late Friday SEC filing provides new details into the deal.

Previous UAB Medicine hit by data breach
Next Bardavon CEO Condon: New partnership accelerates 'rocket ship of growth'